We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Combined Laser Wavelengths Are More Effective

By HospiMedica staff writers
Posted on 05 Apr 2006
An innovative development in laser technology broadens treatment options for dermatologic vascular conditions and makes them more effective.

The Cynergy workstation, a laser workstation for dermatologic uses made by Cynosure (Westford, MA, USA), is equipped with MultiPlex technology, which enables the rapid sequential emission of two laser wavelengths--a pulse-dye laser and aNd:YAG laser--from the same optical fiber with a short time delay between the two pulses. More...
The time delay increases the safety and effectiveness of laser treatment. The workstation has been cleared by the U.S. Food and Drug Administration (FDA).

In clinical studies, treatments using the Cynergy workstation with MultiPlex technology have shown an increased depth of penetration of energy and improved effectiveness in treating port wine stains, and improved outcomes for facial and leg telangiectasia (spider veins), when compared to treatments using either a pulse-dye laser or a Nd:YAG laser individually.

The use of either a pulse-dye laser or a Nd:YAG laser alone has limits, commented Emil Tanghetti, M.D., clinical professor of cosmetic dermatology at the University of California (Davis, CA, USA). However, when combined, these two wavelengths appear to be effective for treating many vascular lesions such as blebbed port wine stains and difficult facial telangiectasia, which were resistant to treatment in the past. This is a truly innovative and exciting development.


Related Links:
Cynosure

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.